News
January 13, 2014

CMS Proposal Would Limit Availability of Medicare D Antidepressants, Immunosuppressants

Healio.com
By Thomas A. Gustafson, PhD Rosemary Maxwell
Find more content tagged:

People

Thomas A. Gustafson, PhD
Thomas A. Gustafson, PhD
Senior Policy Advisor*
Washington, DC
+1 202.942.6570
Email
VCard
Rosemary Maxwell
Rosemary Maxwell
Counsel
Washington, DC
+1 202.942.6040
Email
VCard

Related Content

July 31, 2020
Update: Regulation for COVID-19 clinical trials conducted with medicinal products containing or consisting of GMOs has now been adopted
BioSlice Blog
Subscribe
Subscribe Link

Email Disclaimer

Reject Accept